Search

Your search keyword '"Kalatova D"' showing total 16 results
Start Over Author "Kalatova D"
16 results on '"Kalatova D"'

1. Education Harmonization in Nursing and Social Work as Response to Vulnerable Patient/Client Groups in the new Candidate Member States – Solidarity from European Union (Note)

Author

Otrubova, J., primary, Kalatova, D., additional, Murgova, A., additional, Katunska, M., additional, Zacharova, E., additional, Matulnikova, L., additional, Sramkova, M., additional, Libova, L., additional, Bydzovsky, J., additional, Jankechova, M., additional, Kozon, V., additional, Olah, M., additional, Konosova, H., additional, Karvaj, M., additional, Benca, J., additional, Cauda, R., additional, Sabo, A., additional, and Marks, P., additional

Published
2019
Full Text
View/download PDF

2. Analysis of 9,896 Homeless Patients within an Urban Area in 2014 – 2019 – Social Pathology Leading to Poor Health

Author

Prochazkova, C., primary, Grey, E., additional, Mikolasova, G., additional, Libova, L., additional, Hupkova, I., additional, Pauerova, K., additional, Hochman, R., additional, Jancovic, M., additional, Hofbauer, B., additional, Sramkova, M., additional, Stankova, P., additional, Bosnakova, M., additional, Murgova, A., additional, Katunska, M., additional, Tomanek, P., additional, Mikloskova, M., additional, Miklosko, J., additional, Vlcek, R., additional, Palenikova, M., additional, Drgova, J., additional, Kovac, R., additional, Kimuli, D., additional, Kalatova, D., additional, Kozon, V., additional, Konosova, H., additional, Popovicova, M., additional, Hrindova, T., additional, and Otrubova, J., additional

Published
2019
Full Text
View/download PDF

3. Psychosocial and Medical Intervention before Emergency Travel in Humanitarian Workers – How early is not too late?

Author

Kalatova, D., primary, Subramanian, S., additional, Luliak, M., additional, Gulasova, M., additional, Jancovic, M., additional, Prochazkova, K., additional, Hupkova, I., additional, Otrubova, J., additional, Libova, L., additional, Katunska, M., additional, Popovicova, M., additional, Topolska, A., additional, Sramkova, M., additional, Hofbauerova, B., additional, Murgova, A., additional, and Kimuli, D., additional

Published
2019
Full Text
View/download PDF

5. The Same Question: Are Migrants from the Middle East to Greece Carriers of Resistant Bacteria? In 2015, the Answer was No, but in 2019 it is Yes (Letter to editor

Author

Kalatova, D., primary, Luliak, M., additional, Trilinskaya, Y., additional, Janovicova, L., additional, Simonek, T., additional, Liskova, A., additional, Hamomik, M., additional, Mrazova, M., additional, Krcmery, V., additional, Subramaniam, S., additional, Olah, M., additional, Barkasi, D., additional, and Beresova, A., additional

Published
2019
Full Text
View/download PDF

7. Spectrum of infections in physiotherapy and rehabilitation ward for war victims and veterans from Iraq and Syria (short note)

Author

Khaled, I., primary, Ali Hajj, P., additional, Krcmery, V., additional, Kalatova, D., additional, Gallova, A., additional, Bak, T., additional, Schumman, I., additional, Dudova, Z., additional, Zoller, K., additional, Reith, B., additional, Obtulovic, M., additional, Olah, M., additional, Hrindova, T., additional, and Belovicova, M., additional

Published
2017
Full Text
View/download PDF

8. Low Prevalence of MRSA in Physiotherapy and Gym Facilities in a Greek Refugee Camp

Author

Belovicova, M., primary, Liskova, A., additional, Hrindova, T., additional, Hulkova, V., additional, Polonova, J., additional, Laca, P., additional, Kilikova, M., additional, Kalatova, D., additional, Gallova, A., additional, Bak, T., additional, Spanik, S., additional, Bujdova, N., additional, Krcmery, V., additional, Koleda, P., additional, Olah, M., additional, Nadourova, A., additional, Heinecke, S., additional, and Zoller, K., additional

Published
2017
Full Text
View/download PDF

9. Longitudinal survey of ATB resistance reversibility in children with AIDS of genocide survivors in Cambodia

Author

Shahum, A., primary, Benca, J., additional, Liskova, A., additional, Krcmery, V., additional, Mamova, A., additional, Hruska, J., additional, Zidisinova, M., additional, Michalikova, L., additional, Galbavy, A., additional, Balogova, E., additional, Chabadova, M., additional, Sladeckova, V., additional, Kafkova, J., additional, Putekova, S., additional, Kalavska, A., additional, Kalavsky, E., additional, Jankechova, M., additional, Kalatova, D., additional, Tkacova, L., additional, Murgova, A., additional, Lachytova, L., additional, and Cheng Hoin, H.L.H., additional

Published
2016
Full Text
View/download PDF

10. Experience with Migrants on Balkan Route from the Field Hospital on Slovenian-Croatian Border

Author

Bydzovsky, J., primary, Chrasc, S., additional, Peciar, A., additional, Benca, J., additional, Popelova, M., additional, Sasvary, F., additional, Matel, A., additional, Cernicky, M., additional, Kalatova, D., additional, Nevolna, Z., additional, Kafkova, J., additional, Zollerova, C., additional, Kolibab, M., additional, Putekova, S., additional, Martinkova, J., additional, Mikolasova, G., additional, and Komlosi, M., additional

Published
2016
Full Text
View/download PDF

11. Are migrants from Middle East carriers of multi-resistant bacteria?

Author

Hajj, P.A., primary, Putekova, S., additional, Kabatova, J., additional, Martinkova, J., additional, Zollerova, K., additional, Bucko, L., additional, Radkova, L., additional, Vlcek, R., additional, Grey, E., additional, Olah, M., additional, Simonek, T., additional, Duricova, G., additional, Svitak, R., additional, Ondova, P., additional, Bibza, M., additional, Kolibab, M., additional, Mamova, A., additional, Palenikova, M., additional, Murgova, A., additional, Tkacova, L., additional, Kalatova, D., additional, Jankechova, M., additional, Bydzovsky, J., additional, Khalil, I., additional, Michalikova, L., additional, Mrazova, M., additional, Liskova, A., additional, Herdics, G., additional, Carnicky, M., additional, Krcmery, V., additional, and Khaled, I., additional

Published
2016
Full Text
View/download PDF

13. Neurotoxic side effects of acyclovir: two case reports.

Author

Paluch Z, Trojánek M, Velíšková Z, Mlíchová J, Chrbolka P, Gregorová J, Marques E, Kalatova D, and Pícha D

Subjects
Acyclovir adverse effects, Aged, Antiviral Agents adverse effects, Herpesvirus 3, Human, Humans, Herpes Zoster chemically induced, Herpes Zoster diagnosis, Herpes Zoster drug therapy, Mental Disorders
Abstract

Acyclovir is an antiviral drug frequently used in clinical practice. It is indicated for the treatment of infections caused by herpes simplex virus and varicella zoster virus. The drug has a good safety profile; however, severe side effects may rarely occur during therapy. These include renal failure as a major risk factor for neurotoxic side effects potentially developing within 24-48 hours of therapy initiation. The paper presents the cases of two patients developing neurotoxic side effects while treated for herpes zoster. The aim of the authors is to highlight the potential for developing neurotoxic side effects in high-risk groups such as the elderly, patients with impaired renal function or multiple comorbidities on polypharmacy, or those using nephrotoxic drugs. Acyclovir use could lead to renal impairment and an increase in its plasma and CNS concentrations with severe neuropsychiatric side effects. The neurotoxic side effects are reversible after therapy withdrawal. Thus, in patients developing mental impairment or showing other neurological symptoms during acyclovir therapy, the patient should be promptly assessed for potential drug neurotoxicity, their therapy should be discontinued and drug elimination with forced diuresis or hemodialysis considered. Early recognition of acyclovir neurotoxic side effects can significantly improve a patient's prognosis.

Published
2021

14. Increased platelet activity in tinnitus patients.

Author

Chrbolka P, Alusik S, Kalatova D, and Paluch Z

Subjects
Adult, Blood Coagulation, Female, Humans, Longitudinal Studies, Male, Middle Aged, Thromboxane B2 blood, Blood Platelets metabolism, Thromboxane B2 analogs & derivatives, Tinnitus blood
Abstract

Objective: The aim of our study was to establish whether or not tinnitus patients have higher platelet activity, as measured by plasma 11-dehydro-thromboxane B2 levels, compared with individuals without tinnitus., Methods: The study group included patients without documented organic causes of tinnitus or a cause of non-vascular hearing impairment. Laboratory tests included complete blood count, biochemistry, coagulation activity, and thromboxane levels. To exclude a pathology in the cerebellopontine angle, CT and MRI were performed together with an X-ray scan of cervical vertebrae. For the purpose of this study, blood samples were screened for 11-dehydro-thromboxane B2 levels using commercial kits., Results: A comparison of the main marker of increased platelet activity i.e., thromboxane levels of tinnitus patients with those of a control group, showed increased thromboxane levels in the former. The average plasma concentrations of 11-dehydro-thromboxane B2 were 2.0234±1.80 ng/ml in the group of tinnitus patients and 1.3247±1.33 ng/ml in the control group. Our results showed that patients with tinnitus have significantly higher values of 11-dehydro-thromboxane B2., Conclusion: Tinnitus patients showed higher levels of increased platelet activity, a marker that may play an important role in the pathogenesis of tinnitus.

Published
2020

15. Serotonin syndrome.

Author

Alusik S, Kalatova D, and Paluch Z

Subjects
Humans, Serotonin Syndrome diagnosis, Serotonin Syndrome etiology, Serotonin Syndrome physiopathology, Serotonin Syndrome therapy
Abstract

Serotonin syndrome is a potentially serious clinical condition. In this article, the authors put serotonin syndrome into historical context, discuss its pathophysiology, review in detail its clinical presentations, diagnostic criteria, differential diagnosis and treatment. Special attention is given to drugs that most often cause serotonin syndrome, and the gene polymorphisms involved in the metabolism of these drugs.

Published
2014

16. Fungal neuroinfections and fungaemia: unexpected increase of mortality from invasive fungal infections in 2005-2011 in comparison to 1989-1998: analysis of 210 cases.

Author

Demitrovicova A, Liskova A, Valach M, Izakovic M, Noge A, Baranova J, Kalatova D, Syrovatkova L, Velicova J, Bugykova B, Gulasova I, Seinova D, Mikolasova G, Mutalova M, Pilkova M, Szabo I, Findova L, Madarasz I, Stanzyk M, Mikulickova D, Blazekova M, Jankechova M, Slezakova Z, Kuriplachova G, Visnovsky J, Obrocnikova A, Blumm M, Blumm B, Wolfram S, Zeleny P, Otrubova J, Rudinsky B, Nagyova Z, Vravcova M, Kajaba J, Jexova S, Oravec S, Toth S, Klobucka S, Gerigh J, Schumann F, Ambra R, Bandura P, Bonnack C, Kubisova Z, Palo M, Kalavsky E, Drgona L, Mahesvaari R, and Riedl J

Abstract

Objective: In this short communication we compared the data of fungaemia cases in Slovak hospitals from 1989-1998 published in 1999-2000 with data from 2005-2011., Methods: Risk factors, etiology and outcome of fungaemia between two periods (1989-1998 vs. 2005-2011) were compared and risk factors for death assessed by univariate analysis (CDC 2006 Statistical Package)., Results: In comparison to 1989-1998 when only amphotericin B and fluconazole has been used (55%), in 2005-2011 only 35.2% patients received FLU, but 26.4% received voriconazole, 22% caspofungin and anidulafungin and about 6.6% lipid formulations of Amphotericin B. In etiology, while in 1989-1998 only 37.1% (115/310) represented non-albicans Candida (NAC) and non-Candida yeasts in 2005-2011 already reached 63.7%. The significant increase of breakthrough fungaemia may be a sign of inappropriate empiric therapy.

Published
2013

Catalog

Books, media, physical & digital resources
See catalog results